How doing exercises counteracts the effects of Alzheimer’s disease
Recent research has shown that rats induced with Alzheimer’s disease suffered less from the effects of the disease when subjected to exercise.
How to best assess pain-related behaviors in preclinical studies
Most humans can tell you they’re in pain. However, assessing pain sensitivity in rodents during preclinical studies is a challenge.
The abolition of battery farming has improved chicken welfare, but there are still problems like feather pecking. In the ChickenStress project, we will try to understand better how to reduce stress and improve welfare.
How mice regain their memory: Betaine against Alzheimer’s Disease
As a potential Alzheimer medicine, betaine was tested on an AD animal model in a novel object recognition test. Using video tracking, scientists studied the influence of betaine and betaine transporter on mouse memory.
Diazepam in the battle against Alzheimer’s
Scientists have found out that a low dose of the tranquilizer diazepam reduces the breakdown of neurons, seen in the development of Alzheimer’s disease.
Assessing gait in a mouse model for Leigh Syndrome
There is an unmet medical need to develop clinical effective treatments for Leigh Syndrome and other mitochondrial diseases. Today, Dr. de Haas shares some of her research insights.
Zebrafish help us to understand neurodegenerative and neuromuscular diseases
Teresa Capriello and colleagues use zebrafish to study the neuronal mechanisms of heavy metals in connection to neurodegenerative and neuromuscular diseases.
5 blog posts about brain research
During the annual Brain Awareness Week, international attention focuses on the brain to increase public awareness of the progress and benefits of brain research.
Parkinson's disease research - Relevant measures in pre-clinical studies
Parkinson’s disease: the neurodegenerative disorder that affects mobility in a life-changing way. Learn more about relevant measures in pre-clinical studies.
Alzheimer's research - From prevention research to natural treatment
Experts estimate that by 2050, 100 million people will have Alzheimer’s disease (AD), which is a shockingly large number. Learn more about the research that has been done in order to find a cure.